e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
New treatments for airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Efficacy of high-dose leukocytaphereis using extracorporeal circulation through a large leukocyte-removal filter column in patients with refractory asthma
T. Ishizuka, A. Koike, M. Hatori, S. Matsuzaki, Y. Kamide, H. Aoki, T. Hisada, H. Tsurumaki, A. Ono, Y. Koga, K. Dobashi, K. Suzuki, M. Mori (Maebashi, Japan)
Source:
Annual Congress 2011 - New treatments for airway disease
Session:
New treatments for airway disease
Session type:
Oral Presentation
Number:
3423
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Ishizuka, A. Koike, M. Hatori, S. Matsuzaki, Y. Kamide, H. Aoki, T. Hisada, H. Tsurumaki, A. Ono, Y. Koga, K. Dobashi, K. Suzuki, M. Mori (Maebashi, Japan). Efficacy of high-dose leukocytaphereis using extracorporeal circulation through a large leukocyte-removal filter column in patients with refractory asthma. Eur Respir J 2011; 38: Suppl. 55, 3423
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Comparison of extracorporeal photopheresis efficacy in treated versus non-treated patients with refractory BOS.
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021
The EOLIA trial and ECMO in veno-venous extracorporeal membrane oxygenation therapy: where we are now and where to go
Source: International Congress 2019 – Extracorporeal membrane oxygenation now and in the future
Year: 2019
Weaning from veno-venous extracorporeal membrane oxygenation (ECMO) after prolonged ECMO runtime - should patients be transferred to a specialized center?
Source: International Congress 2017 – Sepsis, infections, ARDS and beyond
Year: 2017
Domiciliary heated high flow cannula therapy delivered with CPAP devices in children
Source: International Congress 2018 – New tools for managing respiratory failure
Year: 2018
Advanced therapies for life-threatening PE: low-dose systemic thrombolysis, catheter-directed thrombolysis and extracorporeal membrane oxygenation (ECMO)
Source: International Congress 2018 – Pulmonary embolism: what we need to know
Year: 2018
A matched pairs analysis of long-term outcomes in first-line i.v. epoprostenol or first-line bosentan treated idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension
Year: 2010
Late Breaking Abstract - Long-term outcome of perioperative extracorporeal membrane oxygenation (ECMO) in patients undergoing pulmonary endarterectomy (PEA).
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017
Long term home high flow nasal cannula therapy in hypercapnic and hypoxic patients after non-invasive ventilation failure – a retrospective analysis
Source: International Congress 2019 – New strategies to treat respiratory failure
Year: 2019
Case presentation: Extracorporeal CO2 removal and veno venous ECMO as bridge to transplantation in refractory hypercapnic respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Efficacy and safety of long-term therapy with Salamol combined with Beclason
versus
Salamol only in patients with mild persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 42s
Year: 2002
Benefits of high-flow nasal cannula oxygen therapy on exercise capacity following acute exacerbation in ILD patients
Source: Virtual Congress 2020 – Best abstracts in the field of pulmonary rehabilitation
Year: 2020
Efficacy and safety of VR475 (budesonide suspension delivered by the VR475 Inhalation System) as add-on treatment in patients with severe asthma (CLEARCUT Study)
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019
Use of heated heliox-driven nebulizer therapy in the treatment of patients with bronchial asthma
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
LATE-BREAKING ABSTRACT: Feasibility of low dose anticoagulation protocol during extracorporeal membrane oxygenation
Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning
Year: 2015
Combination of electronically controlled breathing pattern and improved nebulizer technology for inhaled corticosteroid therapy of severe asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
High flow nasal cannula therapy improves clinical and gas exchange parameters in children with acute bronchiolitis
Source: Annual Congress 2013 –Neonatal and paediatric intensive care
Year: 2013
Efficacy and safety of antibiotic treatment of stable COPD
Source: Annual Congress 2010 - Treatment of bronchial infection: beyond the exacerbations
Year: 2010
In vitro
performance of an improved collapsible holding chamber (CHC) for the delivery of bronchodilators to patients receiving mechanical ventilation
Source: Annual Congress 2011 - Mechanical ventilation and lung injury: new advances
Year: 2011
Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012
12 month follow-up of lung recipients with chronic allograft dysfunction treated with extracorporeal photopheresis (ECP)
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept